Autonomix Medical, Inc.
AMIXNasdaqCIK 1617867HealthcareFiscal year ends Mar 31
Reports and events: 55 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1612:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-030505 |
| 2026-09-1421:02 ET | DEF 14A | Proxy statementPeriod 2026-10-29 | 0001437749-26-030345 |
| 2026-08-2621:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-029024 |
| 2026-08-1323:40 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027429 |
| 2026-07-2815:36 ET | 8-K | 8.01 Other events | 0001437749-26-024597 |
| 2026-07-1521:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-023638 |
| 2026-07-1012:32 ET | 8-K | 8.01 Other events | 0001437749-26-023248 |
| 2026-06-2411:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-021495 |
| 2026-06-1521:28 ET | 10-K/A | Annual report, amendedPeriod 2026-03-31 | 0001437749-26-020686 |
| 2026-05-2720:30 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001437749-26-018573 |
| 2026-02-1122:00 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001437749-26-003816 |
| 2026-01-1612:30 ET | 8-K | 3.01 Delisting notice | 0001437749-26-001381 |
| 2026-01-0914:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-000937 |
| 2025-11-1921:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-25-035733 |
| 2025-11-1222:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034517 |
| 2025-11-0322:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-032798 |
| 2025-09-2321:14 ET | S-1 | Registration statement | 0001437749-25-029750 |
| 2025-09-1220:45 ET | DEF 14A | Proxy statementPeriod 2025-10-30 | 0001437749-25-028954 |
| 2025-09-0321:01 ET | S-1/A | Registration statement, amended | 0001437749-25-028296 |
| 2025-08-2721:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-027890 |
| 2025-08-2610:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-25-027719 |
| 2025-08-2021:03 ET | S-1 | Registration statement | 0001437749-25-027461 |
| 2025-08-1321:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026564 |
| 2025-07-2821:02 ET | 10-K/A | Annual report, amendedPeriod 2025-03-31 | 0001437749-25-023669 |
| 2025-07-2221:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-023246 |
| 2025-05-2921:00 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001437749-25-018831 |
| 2025-04-3012:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-013631 |
| 2025-02-2821:45 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-005739 |
| 2025-02-1313:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-003673 |
| 2025-02-1312:45 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001437749-25-003669 |
| 2025-01-2221:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-001558 |
| 2024-11-2522:12 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-036182 |
| 2024-11-1221:02 ET | S-1/A | Registration statement, amended | 0001437749-24-034531 |
| 2024-11-1213:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034326 |
| 2024-11-0822:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034230 |
| 2024-11-0422:09 ET | 8-K | 8.01 Other events | 0001437749-24-033163 |
| 2024-11-0113:03 ET | S-1 | Registration statement | 0001437749-24-032896 |
| 2024-10-2810:01 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-032175 |
| 2024-10-1721:20 ET | 8-K | 5.07 Shareholder vote results | 0001437749-24-031491 |
| 2024-09-2020:17 ET | 8-K | 3.01 Delisting notice | 0001437749-24-029752 |
| 2024-09-0422:27 ET | DEF 14A | Proxy statementPeriod 2024-10-17 | 0001437749-24-028431 |
| 2024-08-1321:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-026451 |
| 2024-08-1312:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-026162 |
| 2024-07-2621:14 ET | 10-K/A | Annual report, amendedPeriod 2024-03-31 | 0001437749-24-023626 |
| 2024-07-1512:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-022711 |
| 2024-06-2121:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-24-021003 |
| 2024-06-1812:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-020591 |
| 2024-06-1721:14 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-020534 |
| 2024-05-3120:56 ET | 10-K | Annual reportPeriod 2024-03-31 | 0001437749-24-018932 |
| 2024-05-3120:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-018924 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.